eazyplex® Clostridioides difficile is a ready-to-use, lyophilized in vitro diagnostic kit designed for the qualitative detection of toxigenic C. difficile DNA.
The assay targets toxin-associated genes responsible for clinically relevant infections, enabling rapid differentiation between toxigenic and non-toxigenic strains.
Principle of the Method
-
Based on isothermal LAMP amplification for rapid and specific DNA detection
-
No DNA extraction required – sample can be processed directly
-
Results available in approximately 25 minutes
-
Includes an internal inhibition control to ensure assay reliability
| |
eazyplex® C. difficile basic |
eazyplex® C. difficile classic |
eazyplex® C. difficile complete |
| GDH |
|
X |
X |
| Toxin B |
X |
X |
X |
| Toxin A |
|
|
X |
| Binäres Toxin |
|
|
X |
| Inhibitions Kontrolle |
X |
X |
X |
Key Benefits
-
Fast turnaround time compared to conventional culture-based methods
-
Simplified workflow with minimal hands-on time
-
Stable lyophilized reagents ready for immediate use
-
High sensitivity and specificity for detecting toxigenic strains
Intended Use
The assay is intended for clinical microbiology laboratories as an aid in the diagnosis of Clostridioides difficile infection (CDI) in patients with suspected antibiotic-associated diarrhea.
Rapid detection supports:
-
Early initiation of appropriate therapy
-
Timely implementation of infection control measures
-
Improved patient management and antimicrobial stewardship